Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Eisai Co., Ltd.

Market Cap 1,06600Cr 665.17Cr 574.51Cr 529.41Cr 495.55Cr 928.7Cr 63TCr 943.08Cr 6.25TCr 2.44TCr 31TCr 2.5TCr 2.44TCr P/E Ratio 2026
35.6x
P/E Ratio 2027 * 19.1x
Enterprise Value 95TCr 592.03Cr 511.34Cr 471.2Cr 441.06Cr 826.58Cr 56TCr 839.38Cr 5.56TCr 2.17TCr 27TCr 2.22TCr 2.17TCr EV / Sales 2026
1.59x
EV / Sales 2027 * 1.09x
Free-Float
90.73%
Yield 2026
3.28%
Yield 2027 * 4.24%
1 day+1.53%
1 week+0.13%
Current month-5.12%
1 month-18.69%
3 months-21.20%
6 months-17.14%
Current year-18.88%
1 week 3,660
Extreme 3660
3,866
1 month 3,660
Extreme 3660
4,748
Current year 3,660
Extreme 3660
5,243
1 year 3,660
Extreme 3660
5,349
3 years 3,463
Extreme 3463
10,430
5 years 3,463
Extreme 3463
12,765
10 years 3,463
Extreme 3463
12,765
Manager TitleAgeSince
Chief Executive Officer 78 01/06/2003
Director of Finance/CFO 48 01/01/2026
Chief Tech/Sci/R&D Officer 47 01/04/2025
Director TitleAgeSince
Director/Board Member 78 01/06/1983
Director/Board Member 66 14/06/2024
Director/Board Member 67 01/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
+1.53%+0.13%-8.43%-64.98% 665.17Cr
-2.41%+0.14%+39.53%+154.43% 1,01000Cr
+1.07%+3.48%+53.75%+50.64% 58TCr
+1.32%+0.22%+18.35%+65.35% 40TCr
+0.77%0.00%+19.99%+16.80% 33TCr
-1.42%-1.44%+45.50%+8.37% 29TCr
-0.85%-2.86%+22.05%+13.80% 28TCr
+0.44%+3.48%+24.48%+34.39% 28TCr
+1.66%+1.20%-44.67%-47.49% 20TCr
+0.32%+1.61%+19.48%+63.42% 19TCr
Average -0.10%+0.90%+19.00%+29.47% 35.74TCr
Weighted average by Cap. -0.80%+1.00%+29.77%+65.92%

Financials

2026 2027 *
Net sales 82TCr 510.04Cr 440.52Cr 405.94Cr 379.98Cr 712.11Cr 48TCr 723.13Cr 4.79TCr 1.87TCr 24TCr 1.91TCr 1.87TCr 89TCr 555.68Cr 479.94Cr 442.26Cr 413.98Cr 775.82Cr 53TCr 787.84Cr 5.22TCr 2.04TCr 26TCr 2.09TCr 2.04TCr
Net income 4.55TCr 28Cr 25Cr 23Cr 21Cr 40Cr 2.7TCr 40Cr 267.18Cr 104.17Cr 1.32TCr 106.7Cr 104.43Cr 5.63TCr 35Cr 30Cr 28Cr 26Cr 49Cr 3.34TCr 50Cr 330.1Cr 128.7Cr 1.63TCr 131.82Cr 129.02Cr
Net Debt -12TCr -73Cr -63Cr -58Cr -54Cr -102.12Cr -6.95TCr -103.7Cr -687.37Cr -268Cr -3.38TCr -274.5Cr -268.66Cr -9.91TCr -62Cr -53Cr -49Cr -46Cr -86Cr -5.88TCr -88Cr -581.23Cr -226.62Cr -2.86TCr -232.12Cr -227.17Cr
Logo Eisai Co., Ltd.
Eisai Co Ltd is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
Employees
10,917
Date Price Change Volume
12/26/12 3,780.00 ¥ +1.53% 17,35,600
11/26/11 3,723.00 ¥ -0.45% 19,60,900
10/26/10 3,740.00 ¥ -0.08% 19,55,700
09/26/09 3,743.00 ¥ -1.66% 18,11,900
08/26/08 3,806.00 ¥ +0.82% 16,96,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
3,780.00JPY
Average target price
4,607.69JPY
Spread / Average Target
+21.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4523 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!